Healthia Ltd (ASX: HLA) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Healthia Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $216.21 million
P/E Ratio 30.40
Dividend Yield 2.68%
Shares Outstanding 128.32 million
Earnings per share -0.007
Dividend per share 0.04
Year To Date Return -29.83%
Earnings Yield 3.29%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Healthia Ltd (ASX: HLA)
Latest News

chart showing an increasing share price
Growth Shares

2 ASX shares that could be good buys for both growth and dividends

Here are two leading ASX shares that could produce both dividends and growth.

Read more »

A man in a wheelchair stretches both arms into the air in success.
52-Week Highs

This small-cap ASX healthcare share just hit a 52-week high

It's been a great week for the healthcare company's shares...

Read more »

growth charts with small cap written on a sticky note
Small Cap Shares

2 small cap ASX shares for 2022 with big potential

Here are 2 small cap ASX shares with significant growth potential.

Read more »

Group of doctors celebrate by pumping fists in the air
Healthcare Shares

These were the best performing ASX healthcare shares in October

These names sit on the podium for ASX healthcare performers last month.

Read more »

steps to picking asx shares represented by four lightbulbs drawn on chalk board
Growth Shares

2 impressive ASX shares that could be buys in November 2021

Lovisa and Healthia are two ASX shares that could be contenders this month

Read more »

three excited doctors with hands in the air
Share Gainers

These 3 ASX Healthcare shares have surged over 10% today

These ASX Healthcare shares have stood out today.

Read more »

four excited doctors with their hands in the air
Mergers & Acquisitions

Why the Healthia (ASX:HLA) share price is rocketing 10% today

The healthcare company is increasing its presence with another acquisition...

Read more »

The word growth with bles arrows shooting up above it, indicating a share price movement for ASX growth stocks
Growth Shares

2 ASX shares that may be worth looking at this weekend

Healthia and Pacific Current are two ASX shares worth thinking about.

Read more »

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
03 Mar 2022 $0.0200 100.00% Interim 24 Mar 2022
07 Sep 2021 $0.0250 100.00% Final 27 Oct 2021
02 Mar 2021 $0.0200 100.00% Interim 23 Mar 2021
08 Sep 2020 $0.0200 100.00% Final 28 Sep 2020

HLA ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Healthia Ltd

Healthia Ltd is an Australian holding company that operates in the podiatry, physiotherapy, and optometry industry. The company through its holdings owns and operates the My FootDr Podiatry Clinics, Allsports Physiotherapy & Sports Medicine Clinics, iOrthotics, and others. The podiatry division provides podiatry services and podiatry-related services including the manufacturing and sale of orthotics and podiatry-related products, the Physiotherapy division provides physiotherapy and specialty hand therapy services, and the Optometry division provides optometry services. The majority of the revenue is generated from Australia.

HLA Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
17 May 2022 $1.65 $0.01 0.61% 36,448 $1.66 $1.69 $1.64
16 May 2022 $1.64 $-0.02 -1.20% 90,487 $1.72 $1.77 $1.60
13 May 2022 $1.66 $0.02 1.22% 51,783 $1.70 $1.70 $1.64
12 May 2022 $1.64 $-0.05 -2.96% 31,910 $1.68 $1.68 $1.63
11 May 2022 $1.69 $-0.01 -0.59% 86,822 $1.69 $1.71 $1.69
10 May 2022 $1.70 $0.00 0.00% 56,849 $1.70 $1.70 $1.63
09 May 2022 $1.70 $-0.08 -4.51% 57,719 $1.77 $1.78 $1.70
06 May 2022 $1.78 $-0.01 -0.56% 11,081 $1.78 $1.78 $1.78
05 May 2022 $1.78 $0.00 0.00% 81,217 $1.79 $1.79 $1.77
04 May 2022 $1.78 $0.00 0.00% 284,640 $1.79 $1.80 $1.78
03 May 2022 $1.79 $-0.01 -0.56% 55,233 $1.80 $1.81 $1.76
02 May 2022 $1.80 $-0.03 -1.64% 54,009 $1.82 $1.83 $1.78
29 Apr 2022 $1.83 $0.03 1.68% 575,980 $1.79 $1.85 $1.79
28 Apr 2022 $1.79 $-0.04 -2.19% 115,493 $1.85 $1.85 $1.78
27 Apr 2022 $1.83 $-0.01 -0.54% 61,976 $1.84 $1.84 $1.78
26 Apr 2022 $1.85 $-0.03 -1.60% 25,901 $1.90 $1.90 $1.81
22 Apr 2022 $1.87 $0.01 0.54% 14,383 $1.86 $1.87 $1.82
21 Apr 2022 $1.86 $-0.08 -4.12% 23,693 $1.94 $1.94 $1.86
20 Apr 2022 $1.94 $0.05 2.65% 25,598 $1.86 $1.95 $1.86

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
24 Mar 2022 Lisa Dalton Issued 489 $855
Dividend Reinvestment Plan (DRP).
24 Mar 2022 Wesley Coote Issued 5 $8,883
Dividend Reinvestment Plan (DRP).
24 Mar 2022 Paul Wilson Issued 19 $33,953
Dividend Reinvestment Plan (DRP).
08 Mar 2022 Paul Wilson Buy 10 $17,100
On-market trade.
04 Mar 2022 Darren Stewart Sell 18 $34,907
On-market trade.
04 Mar 2022 Paul Wilson Buy 3 $7,481
On-market trade.
03 Mar 2022 Darren Stewart Sell 9 $17,280
On-market trade.
03 Mar 2022 Paul Wilson Buy 6 $11,618
On-market trade.
28 Oct 2021 Wesley Coote Issued 5 $10,668
Dividend Reinvestment Plan (DRP).
28 Oct 2021 Lisa Dalton Issued 458 $856
Dividend Reinvestment Plan (DRP).
28 Oct 2021 Anthony (Tony) Ganter Issued 4 $7,691
Dividend Reinvestment Plan (DRP).
28 Oct 2021 Paul Wilson Issued 18 $34,017
Dividend Reinvestment Plan (DRP).
28 Sep 2021 Lisa Dalton Issued 7 $14,373
Rights issue.
28 Sep 2021 Paul Wilson Issued 317 $570,731
Rights issue.
28 Sep 2021 Wesley Coote Issued 37 $66,855
Rights issue.
28 Sep 2021 Glen Richards Issued 1 $2,070,000
Rights issue.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Ms Lisa Jane Dalton Non-Executive Director May 2018
Ms Dalton is an experienced director, senior executive and company secretary with experience in the healthcare, medical, utilities, manufacturing, childcare, energy, mining and construction sectors. She has experience in leading teams responsible for strategy, governance, risk management, human resources, communication, stakeholder relations and program management. Lisa has participated in 4 ASX listings in the past 5 years. Lisa has practical experience in fit for purpose governance, risk management, strategic planning and motivating teams to find solutions to complex issues. She is Member of Risk Committee.
Dr Glen Frank Richards Non-Executive ChairmanNon-Executive Director May 2018
Dr Richards is a veterinary surgeon and the founder and former CEO of Greencross Limited. Glen has spent over 20 years. Dr Richards is Member of Risk Committee.
Mr Wesley James Coote Chief Executive OfficerManaging Director Apr 2019
Mr Coote is the former Chief Financial Officer and Company Secretary of Greencross Ltd. Prior to Greencross, Wesley worked in Chartered Accounting where he provided business advice within the health sector, property sector and financial services industry. Wesley joined the Group in December 2015 as Chief Financial Officer and Company Secretary and was appointed Group Managing Director and Chief Executive Officer on 29 April 2019.
Mr Paul David Wilson Non-Executive Director May 2018
Mr Wilson was a co-founder, director and shareholder of Mammoth Pet Holdings Pty Ltd (Pet Barn) prior to the merger with Greencross Limited. Prior to founding Mammoth, Paul was the Chief Operating Officer of ShopFast (sold to Coles in 2003). Paul has worked in the retail industry for 26 years with roles including General Manager of Caltex/Boral JV, Vitalgas. He is Chairman of Risk Committee.
Mr Darren Stewart Executive Director May 2018
Mr Stewart is a registered podiatrist and in 2004 co-founded the My FootDr Business with Greg Dower. In 2015, Darren and Greg saw the opportunity to grow their network of clinics through the acquisition of podiatry clinics. Before merging with Balance Podiatry Group in December 2016. Darren provides strategic leadership and direction to the Feet & Ankles business division.
Mr Colin Jonathan Kangisser Non-Executive Director Nov 2020
Mr Kangisser is a registered optometrist with over 30 years optical experience. He founded, grew and exited multiple retail chains including Optic Express and Kays Optical prior to holding executive leadership positions with the OPSM Group and founding TOC in 2005.
Mrs Lisa Michelle Roach Executive Director Apr 2022
Mrs Roach was a founding partner in several of the Allsports Clinics and has over 29 years of experience in the allied health industry; she was also a qualified and practicing physiotherapist for 10 years. Mrs Roach has held an Executive role and been heavily involved and influential within Healthia since IPO. Her current role is Chief Operations and People Officer for Healthia's Bodies & Minds, Feet & Ankles divisions. Mrs Roach has held board positions on Healthia's subsidiary entities since IPO.
Mr Christopher Banks Chief Financial OfficerJoint Company Secretary Apr 2019
-
Ms Julia Murfitt General CounselJoint Company Secretary Feb 2022
-
Christopher Banks Chief Financial OfficerJoint Company Secretary
-
Julia Murfitt General CounselJoint Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
J P Morgan Nominees Australia Pty Limited 10,565,917 11.71%
HSBC Custody Nominees (Australia) Limited 8,434,029 9.35%
My Footdr Holdings Pty Ltd 6,990,694 7.75%
Maximum (NQ) Pty Limited 5,078,764 5.63%
Bridell Pty Limited 5,066,600 5.62%
Chester-LGL Pty Limited 4,333,400 4.80%
DLH Trading Pty Ltd 3,771,465 4.18%
ROM Group Pty Ltd 2,577,232 2.86%
HLA Directors Holdings 2,132,972 2.36%
Willeese Pty Limited 1,208,558 1.34%
GF & LH Richards Super Pty Ltd 1,177,808 1.31%
DPC Investments Pty Ltd 967,317 1.07%
LEGGS Pty Ltd 962,317 1.07%
ZQN Pty Ltd 812,000 0.90%
Mr Christopher Angel & Ms Gina Richman 809,330 0.90%
ABC Investing Pty Ltd 781,310 0.87%
Vassallo Corporate Holdings Pty Ltd 763,654 0.85%
Matthew John Roach 757,267 0.84%
BNP Paribas Nominees Pty Ltd 669,209 0.74%
Mr Anthony Peter Ganter & Ms Deborah Lee Huber 663,212 0.74%

Profile

since

Note